Trials (Sacro Cuore - Don Calabria Hospital): Revision history

15 December 2025

• curprev 12:3312:33, 15 December 2025‎ Francine talk contribs‎ 36,160 bytes +209‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 35,951 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 01:1301:13, 4 December 2025‎ Larysse talk contribs‎ 34,250 bytes +47‎ No edit summary undo

2 December 2025

• curprev 14:0014:00, 2 December 2025‎ Lucas talk contribs‎ m 34,203 bytes +90‎ Update categories. undo

4 December 2023

• curprev 17:5517:55, 4 December 2023‎ Francine talk contribs‎ 34,113 bytes +34,113‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Sacro Cuore - Don Calabria Hospital page '''NCTID''': NCT01940497 '''Title''': A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer '''Study Summary''': This non-randomized, multicenter, open-label study will assess the safety and efficacy of subcutaneously ad..."